CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.
Infection with hepatitis C virus (HCV) is still a major public health problem, and the events leading to hepatocyte infection are not yet fully understood. Combining confocal microscopy with biochemical analysis and studies of infection requirements using pharmacological inhibitors and small interfering RNAs, we show here that engagement of CD81 activates the Rho GTPase family members Rac, Rho, and Cdc42 and that the block of these signaling pathways drastically reduces HCV infectivity. Activation of Rho GTPases mediates actin-dependent relocalization of the HCV E2/CD81 complex to cell-cell contact areas where CD81 comes into contact with the tight-junction proteins occludin, ZO-1, and claudin-1, which was recently described as an HCV coreceptor. Finally, we show that CD81 engagement activates the Raf/MEK/ERK signaling cascade and that this pathway affects postentry events of the virus life cycle. In conclusion, we describe a range of cellular events that are manipulated by HCV to coordinate interactions with its multiple coreceptors and to establish productive infections and find that CD81 is a central regulator of these events.
Brazzoli
Michela
M
Department of Molecular Immunology, Novartis Vaccines and Diagnostics, Siena, Italy. stefania.crotta@novartis.com
Bianchi
Alessia
A
Filippini
Sara
S
Weiner
Amy
A
Zhu
Qing
Q
Pizza
Mariagrazia
M
Crotta
Stefania
S
D015703:Antigens, CD / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000473:pathology; D045744:Cell Line, Tumor; D002999:Clone Cells; D016174:Hepacivirus / Q000145:classification* / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D019698:Hepatitis C, Chronic; D022781:Hepatocytes / Q000821:virology*; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology; D060225:Tetraspanin 28
D015703:Antigens, CD; C554798:CD81 protein, human; D060225:Tetraspanin 28